Search

everythinglearnresearchcommunity

for

Search:↓

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Current treatments for alopecia show no significant long-term benefits.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia areata treatment varies, with no optimal method established yet.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.